Literature DB >> 12942187

[New and established methods in therapy of hair diseases].

R M Trüeb1.   

Abstract

Recently rational drug therapy and potent technologies have been introduced for the treatment of the most frequent hair problems, i.e. finasteride in the treatment of male pattern hair loss, and laser-assisted hair removal systems for hypertrichosis and hirsutism. Together with the availability of such treatments, high technical standards for evaluating their efficacy have been developed, e.g. computer-assisted epiluminiscence microscopy. Besides these physical aspects, life quality has also become an important issue in clinical studies, and is assessed by standardized patient questionnaires. In the treatment of hair loss, women have become reluctant about taking systemic hormones since the results of large epidemiological studies on the risks of hormonal replacement therapy have become public. Topical 17alpha-estradiol offers an alternative, though its efficacy has not been proven. The results of double-blinded, placebo-controlled studies demonstrating efficacy are yet only available for topical minoxidil. In the treatment of alopecia areata, there is no treatment that guarantees regrowth and stable growth of recovered hair. Only topical immunotherapy produces a higher remission rate that the natural evolution of disease. Scarring alopecias are not frequent but they need a careful evaluation, including scalp biopsy, for a precise diagnosis, because of irreversibility and potentially grave cosmetic consequences. The introduction of the modern broad spectrum antimycotic agents has greatly improved the management of infectious scarring alopecias. Finally, developments in hair care and anti-aging medicine are discussed, with special referral to the evolving difficulty of delineating medical science from marketing strategies in this trendy field.

Entities:  

Mesh:

Year:  2003        PMID: 12942187     DOI: 10.1007/s00105-003-0558-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  34 in total

Review 1.  Methods of evaluating hair growth.

Authors:  Alexander J Chamberlain; Rodney P R Dawber
Journal:  Australas J Dermatol       Date:  2003-02       Impact factor: 2.875

2.  Oral ivermectin in the treatment of scabies.

Authors:  M Elmogy; H Fayed; H Marzok; A Rashad
Journal:  Int J Dermatol       Date:  1999-12       Impact factor: 2.736

Review 3.  [Shampoos: composition and clinical applications].

Authors:  R M Trüeb
Journal:  Hautarzt       Date:  1998-12       Impact factor: 0.751

4.  Finasteride in the treatment of men with frontal male pattern hair loss.

Authors:  J Leyden; F Dunlap; B Miller; P Winters; M Lebwohl; D Hecker; S Kraus; H Baldwin; A Shalita; Z Draelos; M Markou; D Thiboutot; M Rapaport; S Kang; T Kelly; D Pariser; G Webster; M Hordinsky; R Rietschel; H I Katz; L Terranella; S Best; E Round; J Waldstreicher
Journal:  J Am Acad Dermatol       Date:  1999-06       Impact factor: 11.527

5.  Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.

Authors:  E Ludwig
Journal:  Br J Dermatol       Date:  1977-09       Impact factor: 9.302

6.  The psychological effects of androgenetic alopecia in men.

Authors:  T F Cash
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

Review 7.  Graying: gerontobiology of the hair follicle pigmentary unit.

Authors:  D J Tobin; R Paus
Journal:  Exp Gerontol       Date:  2001-01       Impact factor: 4.032

Review 8.  [Tinea capitis. Therapeutic options in the post-griseofulvin era].

Authors:  M Möhrenschlager; H C Korting; H P Seidl; J Ring; D Abeck
Journal:  Hautarzt       Date:  2002-12       Impact factor: 0.751

9.  Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

Authors:  K D Kaufman; E A Olsen; D Whiting; R Savin; R DeVillez; W Bergfeld; V H Price; D Van Neste; J L Roberts; M Hordinsky; J Shapiro; B Binkowitz; G J Gormley
Journal:  J Am Acad Dermatol       Date:  1998-10       Impact factor: 11.527

10.  Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.

Authors:  R L DeVillez; J P Jacobs; C A Szpunar; M L Warner
Journal:  Arch Dermatol       Date:  1994-03
View more
  3 in total

Review 1.  [Aging of hair and nails].

Authors:  N Mandt; U Blume-Peytavi
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

2.  Characteristics of androgenetic alopecia in asian.

Authors:  Won-Soo Lee; Hae-Jin Lee
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

3.  Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective Evaluation.

Authors:  Sung Jay Choe; Solam Lee; Jaewoong Choi; Won-Soo Lee
Journal:  Ann Dermatol       Date:  2017-05-11       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.